trending Market Intelligence /marketintelligence/en/news-insights/trending/sea0auxy1pr-tcicikyswq2 content esgSubNav
In This List

CytoDyn raises C$1M via securities offering

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints


CytoDyn raises C$1M via securities offering

CytoDyn Inc. raised about C$1 million through a registered direct offering.

The Canadian developer of HIV treatments issued 1,970,000 shares at 50 Canadian cents each. Each stock will come bundled with a warrant to buy an additional stock for 75 cents apiece.

CytoDyn plans to use net proceeds, expected to be about C$900,000, on clinical trials for its lead product candidate and general corporate purposes.

Paulson Investment Co. LLC acted as placement agent for the offering.